0001104659-24-000913.txt : 20240103 0001104659-24-000913.hdr.sgml : 20240103 20240103165405 ACCESSION NUMBER: 0001104659-24-000913 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lorenz Kevin CENTRAL INDEX KEY: 0001772558 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35366 FILM NUMBER: 24507702 MAIL ADDRESS: STREET 1: C/O NUVEEN STREET 2: 333 W. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fortress Biotech, Inc. CENTRAL INDEX KEY: 0001429260 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 205157386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1111 KANE CONCOURSE STREET 2: SUITE 301 CITY: BAY HARBOR ISLANDS STATE: FL ZIP: 33154 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 1111 KANE CONCOURSE STREET 2: SUITE 301 CITY: BAY HARBOR ISLANDS STATE: FL ZIP: 33154 FORMER COMPANY: FORMER CONFORMED NAME: CORONADO BIOSCIENCES INC DATE OF NAME CHANGE: 20080310 4 1 tm241755-8_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-01-01 0 0001429260 Fortress Biotech, Inc. FBIO 0001772558 Lorenz Kevin C/O FORTRESS BIOTECH, INC. 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 1 0 0 0 0 COMMON STOCK, PAR VALUE $0.001 2024-01-01 4 A 0 3333 0.00 A 24304 D COMMON STOCK, PAR VALUE $0.001 666 I By Spouse Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split. One-third of the shares will vest on each of January 1, 2025, 2026, and 2027, subject to continued service. /s/ Samuel Berry, Attorney-in-Fact 2024-01-03